Green Earth Institute Co.,ltd. · TSE:9212
Green Earth Institute Co.,ltd — Q3 FY2026 Earnings Presentation
20 slides from Green Earth Institute Co.,ltd's earnings presentation, Aug 14, 2026
Slide 1: Q3 FY2026 Financial Results Presentation & Mid-to-Long-Term Vision Progress Report
2026.08.14 From Petroleum To Bio. Bio -manufacturing changes the world . Q3 FY2026 Financial Results Presentation & Mid -to Long -Term Vision Progress Report Toward Becoming the Integrated Industrial Platform Company of Bio -Manufacturing
Slide 2: Recent Environment Surrounding Our Business and Our Response
02 / 20 Recent Environment Surrounding Our Business and Our Response The dawn of the second founding — Announcement of the Mid - to Long -Term Vision On July 15, 2026, we announced our Mid -to Long -Term Vision. The Vision marks the beginning of our company’s “second founding,” with GEI evolving fro
Slide 3: Table of Contents
03 / 20 Table of Contents This document combines the Financial Results Presentation and the Mid -to Long -Term Vision Progress Report , organized into the five sections below. 01 Executive Summary 04 Mid -to Long -Term Vision Progress A review of Q3 results, the full -year forecast, and Mid -to Long
Slide 4: The key messages of this document, summarized in three points
04 / 20 01 — Executive Summary The key messages of this document, summarized in three points A summary of Q3 results for the fiscal year ending September 2026 , the full -year earnings forecast , and Mid -to Long -Term Vision progress . POINT 01 POINT 02 POINT 03 Fiscal Year Ending September 2026 Fu
Slide 5: Three Key Q3 Cumulative Indicators
05 / 20 02 — Q3 Financial Highlights | Key Indicators Three Key Q3 Cumulative Indicators Cumulative from October 2025 to June 2026. Summary of Q3 results based on three axes : sales, profit and loss, and financial condition . Sales Operating Loss Total Assets Cumulative for the third quarter of the
Slide 6: Cumulative profit and loss results for Q3
06 / 20 02 — Q3 Financial Highlights | Income Statement Cumulative profit and loss results for Q3 Comparison of the cumulative Q3 for the fiscal year ending September 2026 and the same period last year (cumulative Q3 for th e fiscal year ending September 2025). For details on sales breakdown , see P
Slide 7: Breakdown of Sales of 274 Million Yen
07 / 20 02 — Q3 Financial Highlights | Sales Breakdown of Sales of 274 Million Yen Q3 Cumulative Sales, FY2026: 274 million yen Development -Type Bio -Foundry: 91 million yen, 33.1% Technology Package: 177 million yen, 64.6% Production -Type Bio -Foundry: 6 million yen (2.2%) Development -Type Bio -
Slide 8: Breakdown of SG&A expenses of 549 million yen
08 / 20 02 — Q3 Financial Highlights | SG&A Expenses Breakdown of SG&A expenses of 549 million yen Q3 Cumulative SG&A Expenses, FY2026: 549 million yen Research and Development Expenses 48.6% Personnel Expenses 37.1% Other 14.3% Research and Development Expenses Personnel Expenses Other 267 million
Slide 9: Structural changes by account
09 / 20 02 — Q3 Financial Highlights | Balance Sheet Structural changes by account BS as of the end of June 2026 is compared at the account title level with the end of the previous fiscal year. The four items marked with ★ are the main reasons for the changes (details explained in the next slide). (
Slide 10: Financial Base for 2031 Targets
10 / 20 02 — Q3 Financial Highlights | Key Account Movements Financial Base for 2031 Targets Four major accounts that changed significantly during Q3. Progress of Semi -Commercial Plant construction and NEDO -related projects is reflected in our financial position. The breakdown of work -in -progres
Slide 11: Full-year forecast unchanged
11 / 20 03 — Progress on Full - Year Earnings Forecast Full -year forecast unchanged Cumulative progress for Q3 against the full -year earnings forecast for the fiscal year ending September 2026 (October 2025 to Se ptember 2026), and Q4 outlook. Account Title Full -Year Outlook Q3 Cumulative Results
Slide 12: The Relationship Between Two-Story Growth Engine and 16 Pipelines
12 / 20 04 — Mid - to Long - Term Vision Progress | Overall Pipeline Map The Relationship Between Two -Story Growth Engine and 16 Pipelines 2F Target Pipelines 3 / 16 Technology Package 3 Projects in total Bio -Fuel Energy Revolution • Woody -biomass ethanol Nippon Paper / Sumitomo / JAL • Paper -in
Slide 13: Progress of joint research and commissioned projects is provided quarterly.
13 / 20 04 — Mid - to Long - Term Vision Progress | 1F Cash Engine | Development - Type Bio - Foundry Progress of joint research and commissioned projects is provided quarterly. Legend Research and Production National Project Development Demonstration Ended ◆Current Status ◆ Projects (3 projects) 20
Slide 14: Commercialization of four products, including cosmetic ingredients, on a quarterly basis
14 / 20 04 — Mid - to Long - Term Vision Progress | 1F Cash Engine | Production - Type Bio - Foundry | Cosmetic Ingredients, etc. Commercialization of four products, including cosmetic ingredients, on a quarterly basis Legend Production Technology Commercial Sample Pilot Test Commercial Production V
Slide 15: Commercialization of three food additive products on a quarterly basis
15 / 20 04 — Mid - to Long - Term Vision Progress | 1F Cash Engine | Production - Type Bio - Foundry | Food Additives Commercialization of three food additive products on a quarterly basis Legend Production Technology Commercial Sample Pilot Test Commercial Production Verification Production ◆Curren
Slide 16: Commercialization of three feed additive products on a quarterly basis
16 / 20 04 — Mid - to Long - Term Vision Progress | 1F Cash Engine | Production - Type Bio - Foundry | Feed Additives Commercialization of three feed additive products on a quarterly basis Legend Production Technology Commercial Sample Pilot Test Commercial Production Verification Production ◆Curren
Slide 17: Progress of three ongoing projects is reported quarterly
17 / 20 04 — Mid - to Long - Term Vision Progress | 1F Cash Engine | Technology Package MILESTONE 01 Progress of three ongoing projects is reported quarterly Semi -Commercial Plant Operation / 1,000 kL *This table is based on the initial plan. Results are updated quarterly. Legend Lab Test Pilot Tes
Slide 18: To Shareholders and Investors
18 / 20 05 — To Shareholders and Investors To Shareholders and Investors In the third quarter, sales declined and losses widened, reflecting a planned upfront investment phase aimed at achieving the 2031 targets . As indicated by construction in progress of +404 million yen and NEDO -related advance
Slide 19: The Future is Green.
The Future is Green. The next chapter of GEI begins here. 01 02 03 04 05 Overturning 30+ years of R&D Two -story Deep tech that IPO 2.0 — toward p etroleum dependence. from RITE era. growth engine generates cash. the cash -generating GEI.
Slide 20: Disclaimer and Forward-Looking Notes
20 / 20 DISCLAIMER Disclaimer and Forward -Looking Notes 1. Forward -Looking Statements The earnings forecasts and forward -looking statements in this document reflect the Company’s judgment based on information curre ntly available and involve risks and uncertainties. Actual results may differ sign
Green Earth Institute — Q3 FY2026 Earnings Presentation on 6ix